Clinical Trials
42 trialsAdapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Fred Hutchinson Cancer Center
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Southwest Autism Research & Resource Center
Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants
Ohio State University Comprehensive Cancer Center
SomaScreen
Amager Hospital
RAINBOW
University of California, Los Angeles
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
University of Chicago
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
ORPHYS
Universitätsklinikum Hamburg-Eppendorf
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
Jonsson Comprehensive Cancer Center
A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Survivors
Taipei City Hospital
Association of Breast Reconstruction Method With Long-term Risk of Psychiatric Disorders
Samsung Medical Center
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
Xiangya Hospital of Central South University
Existential Distress in Patients with Advanced Cancer and Their Caregivers
Universitätsklinikum Hamburg-Eppendorf
EMPOWER
Future Genetics Limited
OPT-IRM
Centre Hospitalier St Anne
Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool
Radboud University Medical Center
AnovaOS Network Powered Patient Registry
Anova Enterprises, Inc
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
Inmune Bio, Inc.
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
LUPE
University of Leipzig
Development of Machine Learning Models for the Prediction of Complications After Colonic, Colorectal and Small Intestine Anastomosis in Psychiatric and Non-psychiatric Patient Collectives (P-Study)
University of Basel
The Development and Validation of EMPOWER-UP: a Generic Questionnaire for Measuring Empowerment in Patient-provider Relationships
Rigshospitalet, Denmark
JACintHE
Centre Hospitalier Universitaire, Amiens
MicrobioPSY
University Hospital, Clermont-Ferrand
The Effectiveness of Nurse Navigators in Cancer Care
Taipei Medical University
GREMO-LCA
University Hospital, Strasbourg, France
MAO
University of Oslo
NWHS
Northern Arizona University
COMO-GMC
University of Aarhus
D-tect
Bispebjerg Hospital
REMIND
Brigham and Women's Hospital
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
VA Office of Research and Development
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development
PROSPER
Association de Recherche Experimentale et Clinique en Chirurgie Digestive
AAT
Children's Hospitals and Clinics of Minnesota
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
National Center for Research Resources (NCRR)
Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
National Center for Research Resources (NCRR)
Study of the Neurobiology of Tourette Syndrome and Related Disorders
National Center for Research Resources (NCRR)
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)